Pretangle tau pathology accrual in the default mode network during the progression of Alzheimer's disease.
Saved in:
| Title: | Pretangle tau pathology accrual in the default mode network during the progression of Alzheimer's disease. |
|---|---|
| Authors: | Kara B; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA.; Cell and Molecular Biology Program, Michigan State University, East Lansing, MI 48824 USA., Kelly IM; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA., Beck JS; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA., Kuhn N; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA., Mufson EJ; Department of Translational Neuroscience, Barrow Neurological Institute, Phoenix, AZ 85013 USA., Vega IE; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA.; Cell and Molecular Biology Program, Michigan State University, East Lansing, MI 48824 USA.; Michigan Alzheimer's Disease Research Center, Ann Arbor, MI 48109 USA., Kanaan NM; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA.; Cell and Molecular Biology Program, Michigan State University, East Lansing, MI 48824 USA.; Michigan Alzheimer's Disease Research Center, Ann Arbor, MI 48109 USA., Counts SE; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA.; Cell and Molecular Biology Program, Michigan State University, East Lansing, MI 48824 USA.; Michigan Alzheimer's Disease Research Center, Ann Arbor, MI 48109 USA.; Department of Family Medicine, Michigan State University, East Lansing, MI 48824 USA.; Trinity Health Hauenstein Neurosciences Center, Grand Rapids, MI 49503 USA. |
| Source: | Molecular neurodegeneration advances [Mol Neurodegener Adv] 2026; Vol. 2 (1), pp. 13. Date of Electronic Publication: 2026 Jan 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9919054337306676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 3059-4944 (Electronic) Linking ISSN: 30594944 NLM ISO Abbreviation: Mol Neurodegener Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41695614 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pretangle tau pathology accrual in the default mode network during the progression of Alzheimer's disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kara+B%22">Kara B</searchLink>; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA.; Cell and Molecular Biology Program, Michigan State University, East Lansing, MI 48824 USA.<br /><searchLink fieldCode="AU" term="%22Kelly+IM%22">Kelly IM</searchLink>; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA.<br /><searchLink fieldCode="AU" term="%22Beck+JS%22">Beck JS</searchLink>; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA.<br /><searchLink fieldCode="AU" term="%22Kuhn+N%22">Kuhn N</searchLink>; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA.<br /><searchLink fieldCode="AU" term="%22Mufson+EJ%22">Mufson EJ</searchLink>; Department of Translational Neuroscience, Barrow Neurological Institute, Phoenix, AZ 85013 USA.<br /><searchLink fieldCode="AU" term="%22Vega+IE%22">Vega IE</searchLink>; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA.; Cell and Molecular Biology Program, Michigan State University, East Lansing, MI 48824 USA.; Michigan Alzheimer's Disease Research Center, Ann Arbor, MI 48109 USA.<br /><searchLink fieldCode="AU" term="%22Kanaan+NM%22">Kanaan NM</searchLink>; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA.; Cell and Molecular Biology Program, Michigan State University, East Lansing, MI 48824 USA.; Michigan Alzheimer's Disease Research Center, Ann Arbor, MI 48109 USA.<br /><searchLink fieldCode="AU" term="%22Counts+SE%22">Counts SE</searchLink>; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA.; Cell and Molecular Biology Program, Michigan State University, East Lansing, MI 48824 USA.; Michigan Alzheimer's Disease Research Center, Ann Arbor, MI 48109 USA.; Department of Family Medicine, Michigan State University, East Lansing, MI 48824 USA.; Trinity Health Hauenstein Neurosciences Center, Grand Rapids, MI 49503 USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229919054337306676%22">Molecular neurodegeneration advances</searchLink> [Mol Neurodegener Adv] 2026; Vol. 2 (1), pp. 13. <i>Date of Electronic Publication: </i>2026 Jan 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central+Ltd%22">BioMed Central Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9919054337306676 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>3059-4944 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2230594944%22">30594944 </searchLink><i>NLM ISO Abbreviation: </i>Mol Neurodegener Adv <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41695614 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s44477-026-00019-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 13 Titles: – TitleFull: Pretangle tau pathology accrual in the default mode network during the progression of Alzheimer's disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kara B – PersonEntity: Name: NameFull: Kelly IM – PersonEntity: Name: NameFull: Beck JS – PersonEntity: Name: NameFull: Kuhn N – PersonEntity: Name: NameFull: Mufson EJ – PersonEntity: Name: NameFull: Vega IE – PersonEntity: Name: NameFull: Kanaan NM – PersonEntity: Name: NameFull: Counts SE IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2026 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 3059-4944 Numbering: – Type: volume Value: 2 – Type: issue Value: 1 Titles: – TitleFull: Molecular neurodegeneration advances Type: main |
| ResultId | 1 |